Q1 2024 Ambu A/S Earnings Call Transcript
/-&
Good morning, everyone, and welcome to this earnings call this morning, where we will report on Ambu's first-quarter results in our fiscal-year 2023-24. My name is Britt Meelby Jensen, and it's a pleasure for me to welcome our new CFO, Henrik Skak Bender, who joined us January 1, to lead our Finance, Legal, and IT function as our Chief Financial Officer.
For the agenda today, Henrik and I will first go through our financial results. I'll present the business update and hand over to Henrik for the financials, and then, we will finish the call with a Q&A session.
So starting with the highlights of the business. We are off to a strong start for our first quarter this year with a 14% organic revenue growth hereof at 25% growth in our key business area, our Endoscopy Solutions area, compared to 3% in Endoscopy last year. This strong revenue growth is partly the reason why we also can report a strong EBIT margin before special items of 10% for the quarter compared to 6%
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |